Clinical PET Cast http://www.clinicalpetcast.com Peter Faulhaber, MD Tue, 06 Jul 2010 18:58:19 +0000 en hourly 1 http://wordpress.org/?v=3.0 Copyright 2009-2010 Peter Faulber, MD clinicalpetcast@gmail.com (Peter Faulhaber, MD) clinicalpetcast@gmail.com (Peter Faulhaber, MD) Science and Medicine 1440 radiology,medical,oncology,nuclear,imaging,radiological,CT,PET Feedback: clinicalpetcast@gmail.com or call (216) 455-0777 Clinical PET Cast is an educational resource for radiologists and other medical professionals regarding PET imaging. Peter Faulhaber is director of Clinical PET at University Hospitals Case Medical Center and Associate Professor of Radiology at Case Western Reserve University in Cleveland, Ohio. He is a leader in clinical PET with 30 years of experience in the field. The focus of this program is to increase knowledge in the clinical applications and principles of PET imaging. Peter Faulhaber, MD No no http://www.clinicalpetcast.com/wp-content/plugins/podpress/images/petcast_v6_144x144.jpg Clinical PET Cast http://www.clinicalpetcast.com 144 144 Copyright 2009-2010 Peter Faulber, MDradiology,medical,oncology,nuclear,imaging,radiological,CT,PETScience & Medicine/Medicineclinicalpetcast@gmail.comPeter Faulhaber, MD Society of Nuclear Medicine 2010 http://feedproxy.google.com/~r/ClinicalPETCast/~3/6iIxs7uwje0/ http://www.clinicalpetcast.com/2010/05/22/society-of-nuclear-medicine-2010/#comments Sun, 23 May 2010 02:45:07 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=108 The annual SNM meeting on June 5th in Salt Lake City is fast approaching.  My preparations for the meeting will keep me busy for the next few weeks, but I will return to podcasting later in June.

Look for my SNM 2010 Review podcast to hear my reflections on the important news from this year’s event.

Thanks for listening.

-Peter

]]> http://www.clinicalpetcast.com/2010/05/22/society-of-nuclear-medicine-2010/feed/ 0 http://www.clinicalpetcast.com/2010/05/22/society-of-nuclear-medicine-2010/ CPC-025 Brain Imaging, Seizures http://feedproxy.google.com/~r/ClinicalPETCast/~3/yyV9JnSs3Ek/ http://www.clinicalpetcast.com/2010/05/14/cpc-025-brain-imaging-seizures/#comments Fri, 14 May 2010 22:00:58 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=106 Dr. Faulhaber concludes his three-part series on non-oncologic brain imaging by discussing refractory seizures. He covers the techniques for evaluating intractable epilepsy, including the role of PET in brain surgery guidance. Dr. Faulhaber also discusses why interictal PET combined with ictal and interictal SPECT will have a better chance of finding an epileptogenic focus. He then discusses the importance of co-registering these scans with software and using subtraction techniques.

]]> http://www.clinicalpetcast.com/2010/05/14/cpc-025-brain-imaging-seizures/feed/ 0 13:34 Dr. Faulhaber concludes his three-part series on non-oncologic brain imaging by discussing refractory seizures. He covers the techniques for evaluating intractable epilepsy, including the role ... Dr. Faulhaber concludes his three-part series on non-oncologic brain imaging by discussing refractory seizures. He covers the techniques for evaluating intractable epilepsy, including the role of PET in brain surgery guidance. Dr. Faulhaber also discusses why interictal PET combined with ictal and interictal SPECT will have a better chance of finding an epileptogenic focus. He then discusses the importance of co-registering these scans with software and using subtraction techniques. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/05/14/cpc-025-brain-imaging-seizures/ CPC-024 Brain Imaging, Dementia http://feedproxy.google.com/~r/ClinicalPETCast/~3/cqyfFJkpjX8/ http://www.clinicalpetcast.com/2010/05/07/cpc-024-brain-imaging-dementia/#comments Fri, 07 May 2010 21:30:38 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=103 Dr. Faulhaber continues his three-part series on non-oncologic brain imaging by covering a wide range of dementia. He examines the challenge of diagnosing from a broad spectrum of symptomatic criteria and looks at the dangers of treating one type of dementia as if it were another. Dr. Faulhaber concludes by examining the promising new agents being used for dementia PET imaging, which offer hope for more accurate diagnoses.

]]> http://www.clinicalpetcast.com/2010/05/07/cpc-024-brain-imaging-dementia/feed/ 0 10:27 Dr. Faulhaber continues his three-part series on non-oncologic brain imaging by covering a wide range of dementia. He examines the challenge of diagnosing from a ... Dr. Faulhaber continues his three-part series on non-oncologic brain imaging by covering a wide range of dementia. He examines the challenge of diagnosing from a broad spectrum of symptomatic criteria and looks at the dangers of treating one type of dementia as if it were another. Dr. Faulhaber concludes by examining the promising new agents being used for dementia PET imaging, which offer hope for more accurate diagnoses. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/05/07/cpc-024-brain-imaging-dementia/ CPC-023 Brain Imaging, Alzheimer’s http://feedproxy.google.com/~r/ClinicalPETCast/~3/b8A14_QRufc/ http://www.clinicalpetcast.com/2010/04/30/cpc-023-brain-imaging-alzheimers-2/#comments Fri, 30 Apr 2010 21:30:21 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=105 Dr. Faulhaber begins a three-part series on non-oncologic brain imaging. He summarizes the CMS approval process, which has led to the evaluation of Alzheimer’s Dementia (AD) with PET. He also examines how imaging can help aid in the early diagnosis and in distinguishing between AD and mild cognitive impairment. Early detection and treatment to delay the onset of AD could potentially have a significant impact on the cost of care, which is currently estimated at 150 billion dollars.

]]> http://www.clinicalpetcast.com/2010/04/30/cpc-023-brain-imaging-alzheimers-2/feed/ 0 13:15 Dr. Faulhaber begins a three-part series on non-oncologic brain imaging. He summarizes the CMS approval process, which has led to the evaluation of ... Dr. Faulhaber begins a three-part series on non-oncologic brain imaging. He summarizes the CMS approval process, which has led to the evaluation of Alzheimer's Dementia (AD) with PET. He also examines how imaging can help aid in the early diagnosis and in distinguishing between AD and mild cognitive impairment. Early detection and treatment to delay the onset of AD could potentially have a significant impact on the cost of care, which is currently estimated at 150 billion dollars. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/04/30/cpc-023-brain-imaging-alzheimers-2/ CPC-022 PET for Clinical Staff, Radiation Therapy http://feedproxy.google.com/~r/ClinicalPETCast/~3/5pRHMcRcLDc/ http://www.clinicalpetcast.com/2010/04/23/cpc-022-pet-for-clinical-staff-radiation-therapy/#comments Fri, 23 Apr 2010 21:31:34 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=100 Dr. Faulhaber concludes his four-part series for clinical staff by looking at the challenges of radiation therapy. He emphasizes the extreme importance of clear communication among the various clinical teams in understanding the plan and possible treatment protocols. For example, using a flat versus a curved table can have a significant impact on the success of the radiation therapy. Dr. Faulhaber also examines the various methods of drawing PET tumor volumes, including constant threshold edge detection and the more accurate gradient edge detection.

]]> http://www.clinicalpetcast.com/2010/04/23/cpc-022-pet-for-clinical-staff-radiation-therapy/feed/ 0 12:50 Dr. Faulhaber concludes his four-part series for clinical staff by looking at the challenges of radiation therapy. He emphasizes the extreme importance of clear communication ... Dr. Faulhaber concludes his four-part series for clinical staff by looking at the challenges of radiation therapy. He emphasizes the extreme importance of clear communication among the various clinical teams in understanding the plan and possible treatment protocols. For example, using a flat versus a curved table can have a significant impact on the success of the radiation therapy. Dr. Faulhaber also examines the various methods of drawing PET tumor volumes, including constant threshold edge detection and the more accurate gradient edge detection. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/04/23/cpc-022-pet-for-clinical-staff-radiation-therapy/ CPC-021 PET for Clinical Staff, Physiologic Parameters http://feedproxy.google.com/~r/ClinicalPETCast/~3/wXsb_fkG3VY/ http://www.clinicalpetcast.com/2010/04/16/cpc-021-pet-for-clinical-staff-physiologic-parameters/#comments Fri, 16 Apr 2010 21:53:50 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=99 Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes the patient’s physiologic parameters that affect what lesions and tumors can and cannot be seen. He also discusses the value of respiratory gating to overcome blurring and the difficulties of minimizing errors when evaluating SUVs.

]]> http://www.clinicalpetcast.com/2010/04/16/cpc-021-pet-for-clinical-staff-physiologic-parameters/feed/ 0 12:49 Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes the patient's physiologic parameters that ... Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes the patient's physiologic parameters that affect what lesions and tumors can and cannot be seen. He also discusses the value of respiratory gating to overcome blurring and the difficulties of minimizing errors when evaluating SUVs. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/04/16/cpc-021-pet-for-clinical-staff-physiologic-parameters/ CPC-020 PET for Clinical Staff, Hardware & Exposure http://feedproxy.google.com/~r/ClinicalPETCast/~3/75nUsYREJ4M/ http://www.clinicalpetcast.com/2010/04/09/cpc-020-pet-for-clinical-staff-hardware-exposure/#comments Fri, 09 Apr 2010 20:11:46 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=97 Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes many of the terms, mechanical functions, and time requirements involved in using a PET/CT scanner. Dr. Faulhaber also covers the potential exposure of patients and clinical staff to radiological dose.

]]> http://www.clinicalpetcast.com/2010/04/09/cpc-020-pet-for-clinical-staff-hardware-exposure/feed/ 0 12:39 Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes many of the terms, mechanical ... Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes many of the terms, mechanical functions, and time requirements involved in using a PET/CT scanner. Dr. Faulhaber also covers the potential exposure of patients and clinical staff to radiological dose. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/04/09/cpc-020-pet-for-clinical-staff-hardware-exposure/ CPC-019 PET for Clinical Staff, Positron Emitters http://feedproxy.google.com/~r/ClinicalPETCast/~3/s8XiuiA-rAo/ http://www.clinicalpetcast.com/2010/04/02/cpc-019-pet-for-clinical-staff-positron-emitters/#comments Fri, 02 Apr 2010 19:00:22 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=95 Dr. Faulhaber begins a four-part series for the entire clinical staff–the nurses, technologists, and physicians directly taking care of the patient. Having some PET background is important, because the patient today is likely to be more sophisticated and educated about treatment and terminology. Dr. Faulhaber begins with an explanation of PET scanners and positron emitters.

]]> http://www.clinicalpetcast.com/2010/04/02/cpc-019-pet-for-clinical-staff-positron-emitters/feed/ 0 11:15 Dr. Faulhaber begins a four-part series for the entire clinical staff--the nurses, technologists, and physicians directly taking care of the patient. Having some PET background ... Dr. Faulhaber begins a four-part series for the entire clinical staff--the nurses, technologists, and physicians directly taking care of the patient. Having some PET background is important, because the patient today is likely to be more sophisticated and educated about treatment and terminology. Dr. Faulhaber begins with an explanation of PET scanners and positron emitters. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/04/02/cpc-019-pet-for-clinical-staff-positron-emitters/ CPC-018 Breast Cancer, Metastases http://feedproxy.google.com/~r/ClinicalPETCast/~3/VMg3P9VTNOI/ http://www.clinicalpetcast.com/2010/03/26/cpc-018-breast-cancer-metastases/#comments Fri, 26 Mar 2010 20:00:28 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=94 Dr. Faulhaber concludes his two part series on breast cancer. He continues beyond using PET to see the primary, to evaluating axillary lymph node metastases and prognosis.

]]> http://www.clinicalpetcast.com/2010/03/26/cpc-018-breast-cancer-metastases/feed/ 0 15:15 Dr. Faulhaber concludes his two part series on breast cancer. He continues beyond using PET to see the primary, to evaluating axillary lymph node metastases ... Dr. Faulhaber concludes his two part series on breast cancer. He continues beyond using PET to see the primary, to evaluating axillary lymph node metastases and prognosis. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/03/26/cpc-018-breast-cancer-metastases/ CPC-017 Breast Cancer, Changes in Therapy http://feedproxy.google.com/~r/ClinicalPETCast/~3/VAi4Z05Kuro/ http://www.clinicalpetcast.com/2010/03/19/cpc-017-breast-cancer-changes-in-therapy/#comments Fri, 19 Mar 2010 21:22:30 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=92 Dr. Faulhaber begins a two part series on PET/CT and breast cancer. PET can have a significant impact on the changes in therapy in conjunction with the availability of multiple chemo therapy regiments.

]]> http://www.clinicalpetcast.com/2010/03/19/cpc-017-breast-cancer-changes-in-therapy/feed/ 0 12:29 Dr. Faulhaber begins a two part series on PET/CT and breast cancer. PET can have a significant impact on the changes in therapy in conjunction ... Dr. Faulhaber begins a two part series on PET/CT and breast cancer. PET can have a significant impact on the changes in therapy in conjunction with the availability of multiple chemo therapy regiments. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/03/19/cpc-017-breast-cancer-changes-in-therapy/ CPC-016 Uterine Malignancies http://feedproxy.google.com/~r/ClinicalPETCast/~3/s2qiY-jU6vk/ http://www.clinicalpetcast.com/2010/03/12/cpc-016-uterine-malignancies/#comments Fri, 12 Mar 2010 22:00:17 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=90 Dr. Faulhaber concludes his three-part session on gynecologic oncology by examining various uterine malignancies and the disturbing fact that the incidence of cancer is increasing but is tempered by a high cure rate.

]]> http://www.clinicalpetcast.com/2010/03/12/cpc-016-uterine-malignancies/feed/ 0 14:13 Dr. Faulhaber concludes his three-part session on gynecologic oncology by examining various uterine malignancies and the disturbing fact that the incidence of cancer is increasing ... Dr. Faulhaber concludes his three-part session on gynecologic oncology by examining various uterine malignancies and the disturbing fact that the incidence of cancer is increasing but is tempered by a high cure rate. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/03/12/cpc-016-uterine-malignancies/ CPC-015 Cervical Cancer http://feedproxy.google.com/~r/ClinicalPETCast/~3/mIPwyA6vSoM/ http://www.clinicalpetcast.com/2010/03/05/cpc-015-cervical-cancer/#comments Fri, 05 Mar 2010 22:29:02 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=89 Dr. Faulhaber continues his three-part session on PET/CT and gynecologic oncology, specifically cervical cancer. The keys to cure include prevention with a vaccine, early detection, and accurate staging.

]]> http://www.clinicalpetcast.com/2010/03/05/cpc-015-cervical-cancer/feed/ 0 16:14 Dr. Faulhaber continues his three-part session on PET/CT and gynecologic oncology, specifically cervical cancer. The keys to cure include prevention with a vaccine, early detection, ... Dr. Faulhaber continues his three-part session on PET/CT and gynecologic oncology, specifically cervical cancer. The keys to cure include prevention with a vaccine, early detection, and accurate staging. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/03/05/cpc-015-cervical-cancer/ CPC-014 CMS and Gynecologic Oncology http://feedproxy.google.com/~r/ClinicalPETCast/~3/YSGQrZVwXsI/ http://www.clinicalpetcast.com/2010/02/26/cpc-014-cms-and-gynecologic-oncology/#comments Fri, 26 Feb 2010 20:45:12 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=87 Dr. Faulhaber begins his three part series on PET/CT and gynecologic oncology by examining Medicare and Medicare Services and their recent decisions impacting gynecologic malignancies.

]]> http://www.clinicalpetcast.com/2010/02/26/cpc-014-cms-and-gynecologic-oncology/feed/ 0 12:43 Dr. Faulhaber begins his three part series on PET/CT and gynecologic oncology by examining Medicare and Medicare Services and their recent decisions impacting gynecologic malignancies. Dr. Faulhaber begins his three part series on PET/CT and gynecologic oncology by examining Medicare and Medicare Services and their recent decisions impacting gynecologic malignancies. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/02/26/cpc-014-cms-and-gynecologic-oncology/ CPC-013 Respiratory Gating Impact http://feedproxy.google.com/~r/ClinicalPETCast/~3/DDyNKoOqGJM/ http://www.clinicalpetcast.com/2010/02/19/cpc-013-respiratory-gating-impact-pt2/#comments Fri, 19 Feb 2010 22:00:43 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=86 Dr. Faulhaber continues his two-part session by examining the impact of respiratory gating on localization, quantification, correlation, and therapy planning.

]]> http://www.clinicalpetcast.com/2010/02/19/cpc-013-respiratory-gating-impact-pt2/feed/ 0 15:17 Dr. Faulhaber continues his two-part session by examining the impact of respiratory gating on localization, quantification, correlation, and therapy planning. Dr. Faulhaber continues his two-part session by examining the impact of respiratory gating on localization, quantification, correlation, and therapy planning. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/02/19/cpc-013-respiratory-gating-impact-pt2/ CPC-012 Respiratory Gating Techniques http://feedproxy.google.com/~r/ClinicalPETCast/~3/U_RPS9eQ1ls/ http://www.clinicalpetcast.com/2010/02/12/cpc-012-respiratory-gating-techniques-pt1/#comments Fri, 12 Feb 2010 22:03:18 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=84 Dr. Faulhaber begins a two-part session by exploring, “Why bother doing respiratory gating?” and the refinements in PET in “stopping” the motion and seeing the lesion better.  He also discusses FDG and how imaging techniques have changed with improvements in hardware, software, and fusion.

]]> http://www.clinicalpetcast.com/2010/02/12/cpc-012-respiratory-gating-techniques-pt1/feed/ 0 13:01 Dr. Faulhaber begins a two-part session by exploring, "Why bother doing respiratory gating?" and the refinements in PET in "stopping" the motion and seeing the ... Dr. Faulhaber begins a two-part session by exploring, "Why bother doing respiratory gating?" and the refinements in PET in "stopping" the motion and seeing the lesion better.nbsp; He also discusses FDG and how imaging techniques have changed with improvements in hardware, software, and fusion. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/02/12/cpc-012-respiratory-gating-techniques-pt1/ CPC-011 Reporting http://feedproxy.google.com/~r/ClinicalPETCast/~3/kDKmEyKgNB8/ http://www.clinicalpetcast.com/2010/02/05/cpc-011/#comments Fri, 05 Feb 2010 22:00:39 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=82 Dr. Faulhaber explores what information (such as malignancy, grade, or previous treatment/surgery) should be specified when a clinician orders a PET, and what information (such as dose, glucose level, and type of scan) should be returned in the final PET report.

]]> http://www.clinicalpetcast.com/2010/02/05/cpc-011/feed/ 0 10:44 Dr. Faulhaber explores what information (such as malignancy, grade, or previous treatment/surgery) should be specified when a clinician orders a PET, and what information (such ... Dr. Faulhaber explores what information (such as malignancy, grade, or previous treatment/surgery) should be specified when a clinician orders a PET, and what information (such as dose, glucose level, and type of scan) should be returned in the final PET report. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/02/05/cpc-011/ CPC-010 Imaging of Gastrointestinal Malignancies Pt3 http://feedproxy.google.com/~r/ClinicalPETCast/~3/WCvP5glh1Gw/ http://www.clinicalpetcast.com/2010/01/29/cpc-010-imaging-of-gastrointestinal-malignancies-pt3/#comments Fri, 29 Jan 2010 21:10:49 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=81 Dr. Faulhaber concludes his three part series on clinical indications by looking at diseases specific to the liver and gastrointestinal stromo tumors.

]]> http://www.clinicalpetcast.com/2010/01/29/cpc-010-imaging-of-gastrointestinal-malignancies-pt3/feed/ 0 14:52 Dr. Faulhaber concludes his three part series on clinical indications by looking at diseases specific to the liver and gastrointestinal stromo tumors. Dr. Faulhaber concludes his three part series on clinical indications by looking at diseases specific to the liver and gastrointestinal stromo tumors. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/01/29/cpc-010-imaging-of-gastrointestinal-malignancies-pt3/ CPC-009 Imaging of Gastrointestinal Malignancies Pt2 http://feedproxy.google.com/~r/ClinicalPETCast/~3/ZrKdwuNuiZM/ http://www.clinicalpetcast.com/2010/01/22/cpc-009-imaging-of-gastrointestinal-malignancies-pt2/#comments Fri, 22 Jan 2010 20:25:01 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=79 Dr. Faulhaber continues his three-part series on clinical indications by looking at PET imaging of the abdomen and comparing treatment planning pre- and post-PET.

]]> http://www.clinicalpetcast.com/2010/01/22/cpc-009-imaging-of-gastrointestinal-malignancies-pt2/feed/ 0 15:11 Dr. Faulhaber continues his three-part series on clinical indications by looking at PET imaging of the abdomen and comparing treatment planning pre- and post-PET. Dr. Faulhaber continues his three-part series on clinical indications by looking at PET imaging of the abdomen and comparing treatment planning pre- and post-PET. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/01/22/cpc-009-imaging-of-gastrointestinal-malignancies-pt2/ CPC-008 Imaging of Gastrointestinal Malignancies Pt1 http://feedproxy.google.com/~r/ClinicalPETCast/~3/D1IH4KsK9mk/ http://www.clinicalpetcast.com/2010/01/15/cpc-008-imaging-of-gastrointestinal-malignancies-pt1/#comments Fri, 15 Jan 2010 22:17:37 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=78 Dr. Faulhaber begins his three part series on clinical indications by looking at diseases of the abdomen and pelvis, specifically colorectal cancer.

]]> http://www.clinicalpetcast.com/2010/01/15/cpc-008-imaging-of-gastrointestinal-malignancies-pt1/feed/ 0 14:37 Dr. Faulhaber begins his three part series on clinical indications by looking at diseases of the abdomen and pelvis, specifically colorectal cancer. Dr. Faulhaber begins his three part series on clinical indications by looking at diseases of the abdomen and pelvis, specifically colorectal cancer. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/01/15/cpc-008-imaging-of-gastrointestinal-malignancies-pt1/ CPC-007 From Prognosis to Treatment Planning http://feedproxy.google.com/~r/ClinicalPETCast/~3/wDddENXgk7o/ http://www.clinicalpetcast.com/2010/01/08/cpc-007-from-prognosis-to-treatment-planning/#comments Fri, 08 Jan 2010 20:56:13 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=71 Dr. Faulhaber looks at the many advantages that image fusion, or PET/CT, has brought to PET, such as increased accuracy in the pinpointing of tumors.

]]> http://www.clinicalpetcast.com/2010/01/08/cpc-007-from-prognosis-to-treatment-planning/feed/ 0 13:01 Dr. Faulhaber looks at the many advantages that image fusion, or PET/CT, has brought to PET, such as increased accuracy in the pinpointing of tumors. Dr. Faulhaber looks at the many advantages that image fusion, or PET/CT, has brought to PET, such as increased accuracy in the pinpointing of tumors. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2010/01/08/cpc-007-from-prognosis-to-treatment-planning/ CPC-006 Moving Beyond Staging & Restaging http://feedproxy.google.com/~r/ClinicalPETCast/~3/WRjHJ98ofoY/ http://www.clinicalpetcast.com/2009/12/18/cpc-006-moving-beyond-staging-restaging/#comments Fri, 18 Dec 2009 08:30:53 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=69 Dr. Faulhaber continues with his discussion of the clinical use of PET. He discusses the usefulness of PET in determining the prognosis of a patient.

]]> http://www.clinicalpetcast.com/2009/12/18/cpc-006-moving-beyond-staging-restaging/feed/ 0 10:53 Dr. Faulhaber continues with his discussion of the clinical use of PET. He discusses the usefulness of PET in determining the prognosis of a patient. Dr. Faulhaber continues with his discussion of the clinical use of PET. He discusses the usefulness of PET in determining the prognosis of a patient. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2009/12/18/cpc-006-moving-beyond-staging-restaging/ CPC-005 Clinical Indication for PET Approved by CMS http://feedproxy.google.com/~r/ClinicalPETCast/~3/r0md7UB1ioE/ http://www.clinicalpetcast.com/2009/12/11/cpc-005-clinical-indication-for-pet-approved-by-cms/#comments Fri, 11 Dec 2009 22:05:39 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=68 Dr. Faulhaber examines how PET has developed clinically as the approval process of CMS has increased.  He begins with a brief review of the value of PET over time and the impact of Fluorine-18 tagged with Glucose as a very powerful imaging agent.

]]> http://www.clinicalpetcast.com/2009/12/11/cpc-005-clinical-indication-for-pet-approved-by-cms/feed/ 0 15:14 Dr. Faulhaber examines how PET has developed clinically as the approval process of CMS has increased. He begins with a brief review of the value of PET over time and the impact of Fluorine-18 tagged with Glucose as a very powerful imaging agent. Dr. Faulhaber examines how PET has developed clinically as the approval process of CMS has increased. He begins with a brief review of the value of PET over time and the impact of Fluorine-18 tagged with Glucose as a very powerful imaging agent. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2009/12/11/cpc-005-clinical-indication-for-pet-approved-by-cms/ Welcome to my Podcast http://feedproxy.google.com/~r/ClinicalPETCast/~3/EGtzU78gpnY/ http://www.clinicalpetcast.com/2009/12/08/welcome-to-my-podcast/#comments Tue, 08 Dec 2009 21:35:26 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=66 The initial episodes of Clinical PET Cast have been well received.  Upcoming programs will cover such wide-ranging topics as:

  • Approval Process of CMS
  • Staging & Restaging
  • Treatment Planning
  • Gastrointestinal Malignancies
  • Respiratory Gating

In the future, I am hoping to expand CPC to include a video podcast companion.  Your feedback will help me direct these plans and to guide the current podcast into areas most relevant to our practices.  Either leave a voicemail at 216-455-0777 or email clinicalpetcast@gmail.com.

-Thanks for listening, Peter

]]> http://www.clinicalpetcast.com/2009/12/08/welcome-to-my-podcast/feed/ 0 http://www.clinicalpetcast.com/2009/12/08/welcome-to-my-podcast/ CPC-004 Intro to Quantitation http://feedproxy.google.com/~r/ClinicalPETCast/~3/Y8ojuMCoK_0/ http://www.clinicalpetcast.com/2009/12/04/cpc-004-intro-to-quantitation/#comments Fri, 04 Dec 2009 22:45:14 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=67 Dr. Faulhaber discusses the concept of quantitation and in particular the Standard Uptake Value or SUV.  Clinical PET relies on semi-quantitative methods which are based on the data acquired from the patient, and how that data is corrected for attenuation.

]]> http://www.clinicalpetcast.com/2009/12/04/cpc-004-intro-to-quantitation/feed/ 0 13:09 Dr. Faulhaber discusses the concept of quantitation and in particular the Standard Uptake Value or SUV.nbsp; Clinical PET relies on semi-quantitative methods which are based ... Dr. Faulhaber discusses the concept of quantitation and in particular the Standard Uptake Value or SUV.nbsp; Clinical PET relies on semi-quantitative methods which are based on the data acquired from the patient, and how that data is corrected for attenuation. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2009/12/04/cpc-004-intro-to-quantitation/ CPC-003 Pitfalls & Artifacts of PET Imaging Part 2 http://feedproxy.google.com/~r/ClinicalPETCast/~3/m0t1prnKYhM/ http://www.clinicalpetcast.com/2009/11/25/cpc-003-pitfalls-artifacts-of-pet-imaging-part-2/#comments Thu, 26 Nov 2009 02:58:17 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=65 Dr. Faulhaber continues this two-part session by examining specific regions of the body that can be quite confounding in the anatomic and physiologic variation. He begins with the head & neck, a very difficult area to interpret.

]]> http://www.clinicalpetcast.com/2009/11/25/cpc-003-pitfalls-artifacts-of-pet-imaging-part-2/feed/ 0 12:56 Dr. Faulhaber continues this two-part session by examining specific regions of the body that can be quite confounding in the anatomic and physiologic variation. He begins with the head neck, a very difficult area to interpret. Dr. Faulhaber continues this two-part session by examining specific regions of the body that can be quite confounding in the anatomic and physiologic variation. He begins with the head neck, a very difficult area to interpret. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2009/11/25/cpc-003-pitfalls-artifacts-of-pet-imaging-part-2/ CPC-002 Pitfalls & Artifacts of PET Imaging Part 1 http://feedproxy.google.com/~r/ClinicalPETCast/~3/abqvUqNKj1M/ http://www.clinicalpetcast.com/2009/11/10/cpc-002-pitfalls-artifacts-of-pet-imaging-part-1/#comments Tue, 10 Nov 2009 20:33:06 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=61 Dr. Peter Faulhaber examines the normal distribution on a PET scan of FDG and what variables to consider.  FDG uptake may vary considerably depending on factors from the patient’s recent activity such as eating, exercise, and excretion.  He also examines the factors that influence uptake on vital organs.

]]> http://www.clinicalpetcast.com/2009/11/10/cpc-002-pitfalls-artifacts-of-pet-imaging-part-1/feed/ 0 16:07 Dr. Peter Faulhaber examines the normal distribution on a PET scan of FDG and what variables to consider.nbsp; FDG uptake may vary considerably depending on ... Dr. Peter Faulhaber examines the normal distribution on a PET scan of FDG and what variables to consider.nbsp; FDG uptake may vary considerably depending on factors from the patientrsquo;s recent activity such as eating, exercise, and excretion.nbsp; He also examines the factors that influence uptake on vital organs. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2009/11/10/cpc-002-pitfalls-artifacts-of-pet-imaging-part-1/ CPC-001 Intro to Clinical PET Cast http://feedproxy.google.com/~r/ClinicalPETCast/~3/1ckECghYsvE/ http://www.clinicalpetcast.com/2009/10/29/cpc-001-intro-to-clinical-pet-cast/#comments Thu, 29 Oct 2009 15:07:34 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=57 This podcast is the first in a series by Dr. Peter Faulhaber, a radiologist at University Hospitals in Cleveland, Ohio. Dr. Faulhaber offers his perspective on various issues of Positron Emission Tomography from a hands-on clinical-based practical approach, based on 30 years of experience.

]]> http://www.clinicalpetcast.com/2009/10/29/cpc-001-intro-to-clinical-pet-cast/feed/ 0 8:26 This podcast is the first in a series by Dr. Peter Faulhaber, a radiologist at University Hospitals in Cleveland, Ohio. Dr. Faulhaber offers his perspective ... This podcast is the first in a series by Dr. Peter Faulhaber, a radiologist at University Hospitals in Cleveland, Ohio. Dr. Faulhaber offers his perspective on various issues of Positron Emission Tomography from a hands-on clinical-based practical approach, based on 30 years of experience. radiology,medical,oncology,nuclear, imaging,radiological,CT,PET Peter Faulhaber, MD no No http://www.clinicalpetcast.com/2009/10/29/cpc-001-intro-to-clinical-pet-cast/ Clinical PET Cast http://feedproxy.google.com/~r/ClinicalPETCast/~3/fnhVHzOe0zw/ http://www.clinicalpetcast.com/2009/10/25/clinical-pet-cast/#comments Sun, 25 Oct 2009 20:35:17 +0000 clinicalpetcast@gmail.com (Peter Faulhaber, MD) http://www.clinicalpetcast.com/?p=58 Clinical PET Cast is an educational resource for radiologists and other medical professionals regarding PET imaging. Peter Faulhaber is director of Clinical PET at University Hospitals Case Medical Center and Associate Professor or Radiology at Case Western Reserve University in Cleveland, Ohio. He is a leader in clinical PET with 30 years of experience in the field. The focus of this program is to increase knowledge in the clinical applications and principles of PET imaging.

]]> http://www.clinicalpetcast.com/2009/10/25/clinical-pet-cast/feed/ 0 http://www.clinicalpetcast.com/2009/10/25/clinical-pet-cast/ Peter Faulhaber, MDnonadultFeedback: clinicalpetcast@gmail.com or call (216) 455-0777